Main Sequence Ventures

mseq.vc

Is a

Company attributes

Industry

Venture capital

Investment

Clean technology

Location

North Ryde, New South Wales

B2X

CEO

Founder

Phil Morle (entrepreneur)

AngelList URL

angel.co/main-seque...ce-ventures

Pitchbook URL

pitchbook.com/profiles...188109-37

Number of Employees (Ranges)

11 – 500

Number of Employees

Full Address

Building 52 5 Julius Avenue North Ryde, New South Wales 2113 Australia

Founded Date

2017

Wellfound ID

main-sequence-ventures

Venture Capital Firm attributes

Invested in

Gilmour Space Technologies

Emesent

Indee Labs

Maxwell MRI

...

Blog

mseq.vc/blog/

Other attributes

Company Operating Status

Active

Main Sequence Ventures is a venture capital that is interested in building global industries. The firm was founded by Bill Bartee, Martin Duursma, Mike Nicholls, Mike Zimmerman, and Phil Morle, in 2017, in Sydney, New South Wales, Australia.

The firm is interested in companies that leverage deep tech and frontier technologies. Investments go to companies such as CSIRO, Advanced Navigation, v2food, Q-CTRL, Kapiche, and Lumachain. Main Sequence Ventures is interested in being a lead investor during Series A through B, seed, and venture rounds.

Timeline

No Timeline data yet.

Associated Investment Funds

Accelerator Batches

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Funding Rounds Participated In

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.